Request Sample Inquiry
Oncology Market

Oncology Market

Oncology Market - Global Industry Assessment & Forecast

img
Healthcare
Number Of Pages # Pages:

145

Base Year:

2023

Date

Jul - 2024

Format:

PDF XLS PPT

Report Code:

VMR-1883

Segments Covered
  • By Cancer Diagnostics & Treatment By Cancer Diagnostics & Treatment Cancer Diagnostics, Cancer Treatment
  • By Indication By Indication Lungs Cancer, Colorectal Cancer, Breast Cancer, Liver Cancer, Bladder Cancer, Head & Neck Cancer, Prostate Cancer, Other Indications
  • By End Use By End Use Hospitals, Diagnostic Laboratories, Diagnostic Imaging Centers, Academia, Specialty Clinics, Other End Uses
  • By Region By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
Base YearBase Year: 2023
Forecast YearsForecast Years: 2024 - 2032
Historical YearsHistorical Years: 2018 - 2022
Revenue 2023Revenue 2023: USD 225.8 Billion
Revenue 2032Revenue 2032: USD 842.6 Billion
Revenue CAGRRevenue CAGR (2024 - 2032): 15.8%
Fastest Growing Region Fastest Growing Region (2024 - 2032) Asia Pacific
Largest Region Largest Region (2023): North America
Customization Offered
  • Cross-segment Market Size and Analysis for Mentioned Segments Cross-segment Market Size and Analysis for Mentioned Segments
  • Additional Company Profiles (Upto 5 With No Cost) Additional Company Profiles (Upto 5 With No Cost)
  • Additional Countries (Apart From Mentioned Countries) Additional Countries (Apart From Mentioned Countries)
  • Country/Region-specific Report Country/Region-specific Report
  • Go To Market Strategy Go To Market Strategy
  • Region Specific Market Dynamics Region Specific Market Dynamics
  • Region Level Market Share Region Level Market Share
  • Import Export Analysis Import Export Analysis
  • Production Analysis Production Analysis
  • Other Others Request Customization Speak To Analyst
  1. Executive Dashboard
    1. Strategic Imperatives
  2. Premium Insights
    1. Top 3 Trends to Watch
    2. Demand and Supply Trends
    3. Top 3 Strategies Followed by Major Players
    4. Top 3 Predictions by Vantage Market Research
    5. Top Investment Pockets
    6. Insights from Primary Respondents
  3. Global Oncology Market - Segment Analysis
    1. Overview
    2. Global Oncology Market, 2016 - 2028 (USD Million)
    3. Global Oncology Market - by Cancer Diagnostics & Treatment
      1. By Cancer Diagnostics
      2. By Cancer Treatment
    4. Global Oncology Market - by Indication
      1. By Lungs Cancer
      2. By Colorectal Cancer
      3. By Breast Cancer
      4. By Liver Cancer
      5. By Bladder Cancer
      6. By Head & Neck Cancer
      7. By Prostate Cancer
      8. By Other Indications
    5. Global Oncology Market - by End Use
      1. By Hospitals
      2. By Diagnostic Laboratories
      3. By Diagnostic Imaging Centers
      4. By Academia
      5. By Specialty Clinics
      6. By Other End Uses
    6. Global Oncology Market - by region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
    7. Market comparative analysis
  4. North America Oncology Market - Segment Analysis
    1. Overview
    2. North America Oncology Market, 2016 - 2028 (USD Million)
    3. North America Oncology Market, by Cancer Diagnostics & Treatment
      1. By Cancer Diagnostics
      2. By Cancer Treatment
    4. North America Oncology Market, by Indication
      1. By Lungs Cancer
      2. By Colorectal Cancer
      3. By Breast Cancer
      4. By Liver Cancer
      5. By Bladder Cancer
      6. By Head & Neck Cancer
      7. By Prostate Cancer
      8. By Other Indications
    5. North America Oncology Market, by End Use
      1. By Hospitals
      2. By Diagnostic Laboratories
      3. By Diagnostic Imaging Centers
      4. By Academia
      5. By Specialty Clinics
      6. By Other End Uses
    6. North America Oncology Market, by Country
      1. U.S.
        1. U.S. Oncology Market, By Cancer Diagnostics & Treatment
          1. By Cancer Diagnostics
          2. By Cancer Treatment
        2. U.S. Oncology Market, By Indication
          1. By Lungs Cancer
          2. By Colorectal Cancer
          3. By Breast Cancer
          4. By Liver Cancer
          5. By Bladder Cancer
          6. By Head & Neck Cancer
          7. By Prostate Cancer
          8. By Other Indications
        3. U.S. Oncology Market, By End Use
          1. By Hospitals
          2. By Diagnostic Laboratories
          3. By Diagnostic Imaging Centers
          4. By Academia
          5. By Specialty Clinics
          6. By Other End Uses
      2. Canada
        1. Canada Oncology Market, By Cancer Diagnostics & Treatment
          1. By Cancer Diagnostics
          2. By Cancer Treatment
        2. Canada Oncology Market, By Indication
          1. By Lungs Cancer
          2. By Colorectal Cancer
          3. By Breast Cancer
          4. By Liver Cancer
          5. By Bladder Cancer
          6. By Head & Neck Cancer
          7. By Prostate Cancer
          8. By Other Indications
        3. Canada Oncology Market, By End Use
          1. By Hospitals
          2. By Diagnostic Laboratories
          3. By Diagnostic Imaging Centers
          4. By Academia
          5. By Specialty Clinics
          6. By Other End Uses
      3. Mexico
        1. Mexico Oncology Market, By Cancer Diagnostics & Treatment
          1. By Cancer Diagnostics
          2. By Cancer Treatment
        2. Mexico Oncology Market, By Indication
          1. By Lungs Cancer
          2. By Colorectal Cancer
          3. By Breast Cancer
          4. By Liver Cancer
          5. By Bladder Cancer
          6. By Head & Neck Cancer
          7. By Prostate Cancer
          8. By Other Indications
        3. Mexico Oncology Market, By End Use
          1. By Hospitals
          2. By Diagnostic Laboratories
          3. By Diagnostic Imaging Centers
          4. By Academia
          5. By Specialty Clinics
          6. By Other End Uses
  5. Europe Oncology Market - Segment Analysis
    1. Overview
    2. Europe Oncology Market, 2016 - 2028 (USD Million)
    3. Europe Oncology Market, by Cancer Diagnostics & Treatment
      1. By Cancer Diagnostics
      2. By Cancer Treatment
    4. Europe Oncology Market, by Indication
      1. By Lungs Cancer
      2. By Colorectal Cancer
      3. By Breast Cancer
      4. By Liver Cancer
      5. By Bladder Cancer
      6. By Head & Neck Cancer
      7. By Prostate Cancer
      8. By Other Indications
    5. Europe Oncology Market, by End Use
      1. By Hospitals
      2. By Diagnostic Laboratories
      3. By Diagnostic Imaging Centers
      4. By Academia
      5. By Specialty Clinics
      6. By Other End Uses
    6. Europe Oncology Market, by Country
      1. Germany
        1. Germany Oncology Market, By Cancer Diagnostics & Treatment
          1. By Cancer Diagnostics
          2. By Cancer Treatment
        2. Germany Oncology Market, By Indication
          1. By Lungs Cancer
          2. By Colorectal Cancer
          3. By Breast Cancer
          4. By Liver Cancer
          5. By Bladder Cancer
          6. By Head & Neck Cancer
          7. By Prostate Cancer
          8. By Other Indications
        3. Germany Oncology Market, By End Use
          1. By Hospitals
          2. By Diagnostic Laboratories
          3. By Diagnostic Imaging Centers
          4. By Academia
          5. By Specialty Clinics
          6. By Other End Uses
      2. UK
        1. UK Market, By Cancer Diagnostics & Treatment
          1. By Cancer Diagnostics
          2. By Cancer Treatment
        2. UK Market, By Indication
          1. By Lungs Cancer
          2. By Colorectal Cancer
          3. By Breast Cancer
          4. By Liver Cancer
          5. By Bladder Cancer
          6. By Head & Neck Cancer
          7. By Prostate Cancer
          8. By Other Indications
        3. UK Market, By End Use
          1. By Hospitals
          2. By Diagnostic Laboratories
          3. By Diagnostic Imaging Centers
          4. By Academia
          5. By Specialty Clinics
          6. By Other End Uses
      3. France
        1. France Oncology Market, By Cancer Diagnostics & Treatment
          1. By Cancer Diagnostics
          2. By Cancer Treatment
        2. France Oncology Market, By Indication
          1. By Lungs Cancer
          2. By Colorectal Cancer
          3. By Breast Cancer
          4. By Liver Cancer
          5. By Bladder Cancer
          6. By Head & Neck Cancer
          7. By Prostate Cancer
          8. By Other Indications
        3. France Oncology Market, By End Use
          1. By Hospitals
          2. By Diagnostic Laboratories
          3. By Diagnostic Imaging Centers
          4. By Academia
          5. By Specialty Clinics
          6. By Other End Uses
      4. Spain
        1. Spain Oncology Market, By Cancer Diagnostics & Treatment
          1. By Cancer Diagnostics
          2. By Cancer Treatment
        2. Spain Oncology Market, By Indication
          1. By Lungs Cancer
          2. By Colorectal Cancer
          3. By Breast Cancer
          4. By Liver Cancer
          5. By Bladder Cancer
          6. By Head & Neck Cancer
          7. By Prostate Cancer
          8. By Other Indications
        3. Spain Oncology Market, By End Use
          1. By Hospitals
          2. By Diagnostic Laboratories
          3. By Diagnostic Imaging Centers
          4. By Academia
          5. By Specialty Clinics
          6. By Other End Uses
      5. Italy
        1. Italy Oncology Market, By Cancer Diagnostics & Treatment
          1. By Cancer Diagnostics
          2. By Cancer Treatment
        2. Italy Oncology Market, By Indication
          1. By Lungs Cancer
          2. By Colorectal Cancer
          3. By Breast Cancer
          4. By Liver Cancer
          5. By Bladder Cancer
          6. By Head & Neck Cancer
          7. By Prostate Cancer
          8. By Other Indications
        3. Italy Oncology Market, By End Use
          1. By Hospitals
          2. By Diagnostic Laboratories
          3. By Diagnostic Imaging Centers
          4. By Academia
          5. By Specialty Clinics
          6. By Other End Uses
      6. BENELUX
        1. BENELUX Oncology Market, By Cancer Diagnostics & Treatment
          1. By Cancer Diagnostics
          2. By Cancer Treatment
        2. BENELUX Oncology Market, By Indication
          1. By Lungs Cancer
          2. By Colorectal Cancer
          3. By Breast Cancer
          4. By Liver Cancer
          5. By Bladder Cancer
          6. By Head & Neck Cancer
          7. By Prostate Cancer
          8. By Other Indications
        3. BENELUX Oncology Market, By End Use
          1. By Hospitals
          2. By Diagnostic Laboratories
          3. By Diagnostic Imaging Centers
          4. By Academia
          5. By Specialty Clinics
          6. By Other End Uses
      7. Rest of Europe
        1. Rest Of Europe Oncology Market, By Cancer Diagnostics & Treatment
          1. By Cancer Diagnostics
          2. By Cancer Treatment
        2. Rest Of Europe Oncology Market, By Indication
          1. By Lungs Cancer
          2. By Colorectal Cancer
          3. By Breast Cancer
          4. By Liver Cancer
          5. By Bladder Cancer
          6. By Head & Neck Cancer
          7. By Prostate Cancer
          8. By Other Indications
        3. Rest Of Europe Oncology Market, By End Use
          1. By Hospitals
          2. By Diagnostic Laboratories
          3. By Diagnostic Imaging Centers
          4. By Academia
          5. By Specialty Clinics
          6. By Other End Uses
  6. Asia Pacific Oncology Market - Segment Analysis
    1. Overview
    2. Asia Pacific Oncology Market, 2016 - 2028 (USD Million)
    3. Asia Pacific Oncology Market, by Cancer Diagnostics & Treatment
      1. By Cancer Diagnostics
      2. By Cancer Treatment
    4. Asia Pacific Oncology Market, by Indication
      1. By Lungs Cancer
      2. By Colorectal Cancer
      3. By Breast Cancer
      4. By Liver Cancer
      5. By Bladder Cancer
      6. By Head & Neck Cancer
      7. By Prostate Cancer
      8. By Other Indications
    5. Asia Pacific Oncology Market, by End Use
      1. By Hospitals
      2. By Diagnostic Laboratories
      3. By Diagnostic Imaging Centers
      4. By Academia
      5. By Specialty Clinics
      6. By Other End Uses
    6. Asia Pacific Oncology Market, by Country
      1. China
        1. China Oncology Market, By Cancer Diagnostics & Treatment
          1. By Cancer Diagnostics
          2. By Cancer Treatment
        2. China Oncology Market, By Indication
          1. By Lungs Cancer
          2. By Colorectal Cancer
          3. By Breast Cancer
          4. By Liver Cancer
          5. By Bladder Cancer
          6. By Head & Neck Cancer
          7. By Prostate Cancer
          8. By Other Indications
        3. China Oncology Market, By End Use
          1. By Hospitals
          2. By Diagnostic Laboratories
          3. By Diagnostic Imaging Centers
          4. By Academia
          5. By Specialty Clinics
          6. By Other End Uses
      2. Japan
        1. Japan Oncology Market, By Cancer Diagnostics & Treatment
          1. By Cancer Diagnostics
          2. By Cancer Treatment
        2. Japan Oncology Market, By Indication
          1. By Lungs Cancer
          2. By Colorectal Cancer
          3. By Breast Cancer
          4. By Liver Cancer
          5. By Bladder Cancer
          6. By Head & Neck Cancer
          7. By Prostate Cancer
          8. By Other Indications
        3. Japan Oncology Market, By End Use
          1. By Hospitals
          2. By Diagnostic Laboratories
          3. By Diagnostic Imaging Centers
          4. By Academia
          5. By Specialty Clinics
          6. By Other End Uses
      3. India
        1. India Oncology Market, By Cancer Diagnostics & Treatment
          1. By Cancer Diagnostics
          2. By Cancer Treatment
        2. India Oncology Market, By Indication
          1. By Lungs Cancer
          2. By Colorectal Cancer
          3. By Breast Cancer
          4. By Liver Cancer
          5. By Bladder Cancer
          6. By Head & Neck Cancer
          7. By Prostate Cancer
          8. By Other Indications
        3. India Oncology Market, By End Use
          1. By Hospitals
          2. By Diagnostic Laboratories
          3. By Diagnostic Imaging Centers
          4. By Academia
          5. By Specialty Clinics
          6. By Other End Uses
      4. South Korea
        1. South Korea Oncology Market, By Cancer Diagnostics & Treatment
          1. By Cancer Diagnostics
          2. By Cancer Treatment
        2. South Korea Oncology Market, By Indication
          1. By Lungs Cancer
          2. By Colorectal Cancer
          3. By Breast Cancer
          4. By Liver Cancer
          5. By Bladder Cancer
          6. By Head & Neck Cancer
          7. By Prostate Cancer
          8. By Other Indications
        3. South Korea Oncology Market, By End Use
          1. By Hospitals
          2. By Diagnostic Laboratories
          3. By Diagnostic Imaging Centers
          4. By Academia
          5. By Specialty Clinics
          6. By Other End Uses
      5. South East Asia
        1. South East Asia Oncology Market, By Cancer Diagnostics & Treatment
          1. By Cancer Diagnostics
          2. By Cancer Treatment
        2. South East Asia Oncology Market, By Indication
          1. By Lungs Cancer
          2. By Colorectal Cancer
          3. By Breast Cancer
          4. By Liver Cancer
          5. By Bladder Cancer
          6. By Head & Neck Cancer
          7. By Prostate Cancer
          8. By Other Indications
        3. South East Asia Oncology Market, By End Use
          1. By Hospitals
          2. By Diagnostic Laboratories
          3. By Diagnostic Imaging Centers
          4. By Academia
          5. By Specialty Clinics
          6. By Other End Uses
      6. Rest of Asia Pacific
        1. Rest of Asia Pacific Oncology Market, By Cancer Diagnostics & Treatment
          1. By Cancer Diagnostics
          2. By Cancer Treatment
        2. Rest of Asia Pacific Oncology Market, By Indication
          1. By Lungs Cancer
          2. By Colorectal Cancer
          3. By Breast Cancer
          4. By Liver Cancer
          5. By Bladder Cancer
          6. By Head & Neck Cancer
          7. By Prostate Cancer
          8. By Other Indications
        3. Rest of Asia Pacific Oncology Market, By End Use
          1. By Hospitals
          2. By Diagnostic Laboratories
          3. By Diagnostic Imaging Centers
          4. By Academia
          5. By Specialty Clinics
          6. By Other End Uses
  7. Latin America Oncology Market - Segment Analysis
    1. Overview
    2. Latin America Oncology Market, 2016 - 2028 (USD Million)
    3. Latin America Oncology Market, by Cancer Diagnostics & Treatment
      1. By Cancer Diagnostics
      2. By Cancer Treatment
    4. Latin America Oncology Market, by Indication
      1. By Lungs Cancer
      2. By Colorectal Cancer
      3. By Breast Cancer
      4. By Liver Cancer
      5. By Bladder Cancer
      6. By Head & Neck Cancer
      7. By Prostate Cancer
      8. By Other Indications
    5. Latin America Oncology Market, by End Use
      1. By Hospitals
      2. By Diagnostic Laboratories
      3. By Diagnostic Imaging Centers
      4. By Academia
      5. By Specialty Clinics
      6. By Other End Uses
    6. Latin America Oncology Market, by Country
      1. Brazil
        1. Brazil Oncology Market, By Cancer Diagnostics & Treatment
          1. By Cancer Diagnostics
          2. By Cancer Treatment
        2. Brazil Oncology Market, By Indication
          1. By Lungs Cancer
          2. By Colorectal Cancer
          3. By Breast Cancer
          4. By Liver Cancer
          5. By Bladder Cancer
          6. By Head & Neck Cancer
          7. By Prostate Cancer
          8. By Other Indications
        3. Brazil Oncology Market, By End Use
          1. By Hospitals
          2. By Diagnostic Laboratories
          3. By Diagnostic Imaging Centers
          4. By Academia
          5. By Specialty Clinics
          6. By Other End Uses
      2. Argentina
        1. Argentina Oncology Market, By Cancer Diagnostics & Treatment
          1. By Cancer Diagnostics
          2. By Cancer Treatment
        2. Argentina Oncology Market, By Indication
          1. By Lungs Cancer
          2. By Colorectal Cancer
          3. By Breast Cancer
          4. By Liver Cancer
          5. By Bladder Cancer
          6. By Head & Neck Cancer
          7. By Prostate Cancer
          8. By Other Indications
        3. Argentina Oncology Market, By End Use
          1. By Hospitals
          2. By Diagnostic Laboratories
          3. By Diagnostic Imaging Centers
          4. By Academia
          5. By Specialty Clinics
          6. By Other End Uses
      3. Rest of Latin America
        1. Rest of Latin America Oncology Market, By Cancer Diagnostics & Treatment
          1. By Cancer Diagnostics
          2. By Cancer Treatment
        2. Rest of Latin America Oncology Market, By Indication
          1. By Lungs Cancer
          2. By Colorectal Cancer
          3. By Breast Cancer
          4. By Liver Cancer
          5. By Bladder Cancer
          6. By Head & Neck Cancer
          7. By Prostate Cancer
          8. By Other Indications
        3. Rest of Latin America Oncology Market, By End Use
          1. By Hospitals
          2. By Diagnostic Laboratories
          3. By Diagnostic Imaging Centers
          4. By Academia
          5. By Specialty Clinics
          6. By Other End Uses
  8. Middle East & Africa Oncology Market - Segment Analysis
    1. Overview
    2. Middle East & Africa Oncology Market, 2016 - 2028 (USD Million)
    3. Middle East & Africa Oncology Market, by Cancer Diagnostics & Treatment
      1. By Cancer Diagnostics
      2. By Cancer Treatment
    4. Middle East & Africa Oncology Market, by Indication
      1. By Lungs Cancer
      2. By Colorectal Cancer
      3. By Breast Cancer
      4. By Liver Cancer
      5. By Bladder Cancer
      6. By Head & Neck Cancer
      7. By Prostate Cancer
      8. By Other Indications
    5. Middle East & Africa Oncology Market, by End Use
      1. By Hospitals
      2. By Diagnostic Laboratories
      3. By Diagnostic Imaging Centers
      4. By Academia
      5. By Specialty Clinics
      6. By Other End Uses
    6. Middle East & Africa Oncology Market, by Country
      1. GCC Countries
        1. GCC Countries Oncology Market, By Cancer Diagnostics & Treatment
          1. By Cancer Diagnostics
          2. By Cancer Treatment
        2. GCC Countries Oncology Market, By Indication
          1. By Lungs Cancer
          2. By Colorectal Cancer
          3. By Breast Cancer
          4. By Liver Cancer
          5. By Bladder Cancer
          6. By Head & Neck Cancer
          7. By Prostate Cancer
          8. By Other Indications
        3. GCC Countries Oncology Market, By End Use
          1. By Hospitals
          2. By Diagnostic Laboratories
          3. By Diagnostic Imaging Centers
          4. By Academia
          5. By Specialty Clinics
          6. By Other End Uses
      2. South Africa
        1. South Africa Oncology Market, By Cancer Diagnostics & Treatment
          1. By Cancer Diagnostics
          2. By Cancer Treatment
        2. South Africa Oncology Market, By Indication
          1. By Lungs Cancer
          2. By Colorectal Cancer
          3. By Breast Cancer
          4. By Liver Cancer
          5. By Bladder Cancer
          6. By Head & Neck Cancer
          7. By Prostate Cancer
          8. By Other Indications
        3. South Africa Oncology Market, By End Use
          1. By Hospitals
          2. By Diagnostic Laboratories
          3. By Diagnostic Imaging Centers
          4. By Academia
          5. By Specialty Clinics
          6. By Other End Uses
      3. Rest of Middle East & Africa
        1. Rest of Middle East & Africa Oncology Market, By Cancer Diagnostics & Treatment
          1. By Cancer Diagnostics
          2. By Cancer Treatment
        2. Rest of Middle East & Africa Oncology Market, By Indication
          1. By Lungs Cancer
          2. By Colorectal Cancer
          3. By Breast Cancer
          4. By Liver Cancer
          5. By Bladder Cancer
          6. By Head & Neck Cancer
          7. By Prostate Cancer
          8. By Other Indications
        3. Rest of Middle East & Africa Oncology Market, By End Use
          1. By Hospitals
          2. By Diagnostic Laboratories
          3. By Diagnostic Imaging Centers
          4. By Academia
          5. By Specialty Clinics
          6. By Other End Uses
  9. Key Market Dynamics
    1. Introduction
    2. Market Drivers
    3. Market Restraints
    4. Market Opportunities
    5. Porter's Five Forces Analysis
    6. PEST Analysis
    7. Regulatory Landscape
    8. Technology Landscape
    9. Regional Market Trends
  10. COVID 19 Impact Analysis
    1. Key strategies undertaken by companies to tackle COVID-19
    2. Short term dynamics
    3. Long term dynamics
  11. Marketing Stratagy Analysis
    1. Marketing Channel
    2. Direct Marketing
    3. Indirect Marketing
    4. Marketing Channel Development Trends
  12. Competative Landscape
    1. Competition Matrix - 2021
    2. Company Market Share Analysis - 2021
    3. Key Company Activities, 2018 - 2021
    4. Strategic Developments - Heat Map Analysis
    5. Company Offering Evaluation
    6. Company Regional Presence Evaluation
  13. Company Profiles
    1. Ability Pharma
    2. Thermo Fisher Scientific Inc.
    3. Abbvie Inc.
    4. Takeda Pharmaceutical Co. Ltd.
    5. Astrazeneca Plc.
    6. Pfizer Inc.
    7. Sysmex Corporation
    8. Bayer Ag
    9. Agilent Technologies Inc.
    10. Biogenex
  14. Key Primary Respondents - VERBATIM
  15. Discussion Guide
  16. Customization Offered
  17. Annexure
  18. List of Figures
  19. List of Tables
  20. List of Abbreviations
Vantage Market Research | 17-Nov-2022
Oncology Market to Reach Valuation of USD 447.3 Billion by 2028 – High Prevalence and Incidence of Cancer Disease Drives the Market
FAQ
Frequently Asked Question

  • The global Oncology valued at USD 225.8 Billion in 2023 and is expected to reach USD 842.6 Billion in 2032 growing at a CAGR of 15.8%.

  • The prominent players in the market are Ability Pharma, Thermo Fisher Scientific Inc., Abbvie Inc., Takeda Pharmaceutical Co. Ltd., Astrazeneca Plc., Pfizer Inc., Sysmex Corporation, Bayer Ag, Agilent Technologies Inc., Biogenex.

  • The market is project to grow at a CAGR of 15.8% between 2024 and 2032.

  • The driving factors of the Oncology include

    • The growing worldwide occurrence of most cancers is a pivotal factor shaping healthcare priorities, treatment strategies, and research endeavors aimed at preventing the growing burden of most cancers-related morbidity and mortality

  • North America was the leading regional segment of the Oncology in 2023.

Related Reports
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies Privacy Policy